General Information of the Compound
Compound ID
CP0227843
Compound Name
ARFORMOTEROL TARTRATE
    Show/Hide
Synonyms
67346-49-0
Arformoterol
Arformoterol tartrate
Brovana
Brovana (TN)
CHEBI:408174
CHEMBL1363
F91H02EBWT
Formoterol/fluticasone propionate
UNII-F91H02EBWT
    Show/Hide
Structure
Formula
C19H24N2O4
Molecular Weight
344.411
Canonical SMILES
COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1
    Show/Hide
InChI
InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1
    Show/Hide
InChIKey
BPZSYCZIITTYBL-YJYMSZOUSA-N
CAS
208102-40-3
289657-27-8
299964-45-7
67346-49-0
Physicochemical Property
logP
2.2233
Rotatable Bonds
9
Heavy Atom Count
25
Polar Areas
90.82
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
5
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 3083544
SID: 14827391
ChEMBL ID
CHEMBL1363
DrugBank ID
DB01274
Clinical Information about the Compound
Drug 1 ( Arformoterol )
Drug Name Arformoterol
Company Sepracor phamaceuticals
Indication
Chronic obstructive pulmonary disease
Approved
Asthma
Phase 4
Target(s)
Adrenergic receptor beta-2 (ADRB2)
Agonist